Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases $15,823.89 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 15,363 shares of Retractable Technologies stock in a transaction dated Wednesday, April 17th. The stock was purchased at an average cost of $1.03 per share, for a total transaction of $15,823.89. Following the completion of the purchase, the chief executive officer now owns 14,352,831 shares in the company, valued at approximately $14,783,415.93. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.

Retractable Technologies Trading Down 1.9 %

Shares of NYSE:RVP traded down $0.02 during trading on Thursday, reaching $1.02. The stock had a trading volume of 76,907 shares, compared to its average volume of 78,911. The firm’s fifty day moving average is $1.21 and its 200 day moving average is $1.16. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.41 and a current ratio of 8.28. Retractable Technologies, Inc. has a 52 week low of $0.95 and a 52 week high of $1.88. The stock has a market cap of $30.54 million, a price-to-earnings ratio of -4.29 and a beta of 2.11.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Retractable Technologies in a research note on Wednesday. They issued a “hold” rating on the stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of RVP. Millennium Management LLC bought a new position in Retractable Technologies during the second quarter worth $880,000. Vanguard Group Inc. boosted its stake in Retractable Technologies by 12.6% during the first quarter. Vanguard Group Inc. now owns 1,092,079 shares of the company’s stock worth $5,188,000 after acquiring an additional 122,231 shares in the last quarter. AQR Capital Management LLC boosted its stake in Retractable Technologies by 512.2% during the second quarter. AQR Capital Management LLC now owns 107,890 shares of the company’s stock worth $413,000 after acquiring an additional 90,267 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Retractable Technologies by 248.3% during the second quarter. Renaissance Technologies LLC now owns 121,900 shares of the company’s stock worth $467,000 after acquiring an additional 86,900 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its stake in Retractable Technologies by 314.2% during the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 58,400 shares of the company’s stock worth $96,000 after acquiring an additional 44,300 shares in the last quarter. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.